rituximab,ibrutinib
janssen,abbvie
['rituximab', 'lymsm', 'ibru', 'ritux']
dr thieblemont presents ielsg47/malibu study of ibrutinib and rituximab in mzl. excellent orr and encouraging cr rates in both subtypes but shorter pfs in nmzl #17icml #lymsm 
Haematologist, Sir Charles Gairdner & Hollywood Private Hospitals
Professor, University of Western Australia
Founder/Director, Blood Cancer Research WA #lymSM